Cytomedix to Present At Rodman & Renshaw 10th Annual Healthcare Conference On Wednesday, Nov. 12, 2008
20 oct. 2008 08h00 HE
|
Cytomedix, Inc.
ROCKVILLE, Md., Oct. 20, 2008 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (AMEX:GTF) today announced that Chief Executive Officer Martin Rosendale will present an overview of the Company at the Rodman &...
Cytomedix On Track With Sales and Marketing Efforts for AutoloGel System and Further Development of CT-112 Peptide, Annual Meeting Told
19 sept. 2008 13h00 HE
|
Cytomedix, Inc.
ROCKVILLE, Md., Sept. 19, 2008 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (AMEX:GTF) Chief Executive Officer Martin Rosendale told the Annual Meeting of Shareholders today that the Company is progressing...
Cytomedix Appoints Dr. Peter A. Clausen as Vice President of Business Development
10 sept. 2008 07h30 HE
|
Cytomedix, Inc.
ROCKVILLE, Md., Sept. 10, 2008 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (AMEX:GTF) today announced the appointment of Dr. Peter Anton Clausen, Ph.D., a seasoned biochemist with nearly 15 years experience...
Cytomedix Completes $1.5 Million Capital Raise
08 sept. 2008 07h30 HE
|
Cytomedix, Inc.
ROCKVILLE, Md., Sept. 8, 2008 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (AMEX:GTF) today announced that it has successfully completed a $1.5 million capital raise through the issuance of two million shares...
Cytomedix CEO Martin Rosendale Discusses Company in Interview With The Wall Street Transcript
19 août 2008 07h30 HE
|
Cytomedix, Inc.
ROCKVILLE, Md., Aug. 19, 2008 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (AMEX:GTF) today announced that The Wall Street Transcript (TWST) has published an in-depth interview with Chief Executive Officer...
Cytomedix Retains Dr. David F. Counts, Inventor of Company's Anti-Inflammatory Peptide Patent
28 juil. 2008 07h30 HE
|
Cytomedix, Inc.
ROCKVILLE, Md., July 28, 2008 (PRIME NEWSWIRE) -- Cytomedix, Inc. (AMEX:GTF) today announced that David F. Counts Ph.D., a leading pharmacologist and medical researcher who discovered the Company's...
Cytomedix CEO Issues Shareholder Update
16 juil. 2008 07h30 HE
|
Cytomedix, Inc.
ROCKVILLE, Md., July 16, 2008 (PRIME NEWSWIRE) -- Cytomedix, Inc. (AMEX:GTF) announced today that Chief Executive Officer Martin Rosendale issued the following letter to shareholders providing a...
Cytomedix Unveils Clinical Plans for the Development of Anti-Inflammatory Peptides
12 juin 2008 07h30 HE
|
Cytomedix, Inc.
ROCKVILLE, Md., June 12, 2008 (PRIME NEWSWIRE) -- Cytomedix, Inc. (AMEX:GTF) today announced plans for entering the multi-billion dollar anti-inflammatory market with patent protected peptides derived...
Cytomedix Announces Transition of Leadership
09 juin 2008 07h30 HE
|
Cytomedix, Inc.
ROCKVILLE, Md., June 9, 2008 (PRIME NEWSWIRE) -- Cytomedix, Inc. (AMEX:GTF) today announced that Kshitij Mohan, Ph.D. will step down as Chairman and CEO effective June 30, 2008, but will continue as a...
Cytomedix Joins the Acute Long Term Hospital Association (ALTHA) as An Allied Member
14 mai 2008 07h30 HE
|
Cytomedix, Inc.
ROCKVILLE, Md., May 14, 2008 (PRIME NEWSWIRE) -- Cytomedix, Inc. (AMEX:GTF) today announced that it has joined the Acute Long Term Hospital Association (ALTHA) as a Silver member and will be...